Supernus Pharmaceuticals
SUPN
#4517
Rank
โ‚น148.53 B
Marketcap
โ‚น2,696
Share price
0.91%
Change (1 day)
14.29%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): โ‚น65.16

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น66.28. In 2022 the company made an earnings per share (EPS) of โ‚น94.80 an increase over its 2021 EPS that were of โ‚น85.57.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น65.16-31.26%
2022โ‚น94.8010.78%
2021โ‚น85.57-57.68%
2020โ‚น202.1812.09%
2019โ‚น180.370.47%
2018โ‚น179.5389.38%
2017โ‚น94.80-38.59%
2016โ‚น154.36534.48%
2015โ‚น24.33-211.54%
2014-โ‚น21.81-91.1%
2013-โ‚น244.9739.46%
2012-โ‚น175.66-69.27%
2011-โ‚น571.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,621 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น455.48 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น333.06 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น249.35 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,182 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA